These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 34792325)

  • 1. Clinical Antiviral Drug Arbidol Inhibits Infection by SARS-CoV-2 and Variants through Direct Binding to the Spike Protein.
    Shuster A; Pechalrieu D; Jackson CB; Abegg D; Choe H; Adibekian A
    ACS Chem Biol; 2021 Dec; 16(12):2845-2851. PubMed ID: 34792325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Coronavirus Entry
    Outlaw VK; Bovier FT; Mears MC; Cajimat MN; Zhu Y; Lin MJ; Addetia A; Lieberman NAP; Peddu V; Xie X; Shi PY; Greninger AL; Gellman SH; Bente DA; Moscona A; Porotto M
    mBio; 2020 Oct; 11(5):. PubMed ID: 33082259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simulation of Molecular Dynamics of SARS-CoV-2 S-Protein in the Presence of Multiple Arbidol Molecules: Interactions and Binding Mode Insights.
    Borisevich SS; Khamitov EM; Gureev MA; Yarovaya OI; Rudometova NB; Zybkina AV; Mordvinova ED; Shcherbakov DN; Maksyutov RA; Salakhutdinov NF
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV-2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID-19 infections.
    Musarrat F; Chouljenko V; Dahal A; Nabi R; Chouljenko T; Jois SD; Kousoulas KG
    J Med Virol; 2020 Oct; 92(10):2087-2095. PubMed ID: 32374457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research Progress on Spike-Dependent SARS-CoV-2 Fusion Inhibitors and Small Molecules Targeting the S2 Subunit of Spike.
    Freidel MR; Armen RS
    Viruses; 2024 Apr; 16(5):. PubMed ID: 38793593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unraveling the mechanism of arbidol binding and inhibition of SARS-CoV-2: Insights from atomistic simulations.
    Padhi AK; Seal A; Khan JM; Ahamed M; Tripathi T
    Eur J Pharmacol; 2021 Mar; 894():173836. PubMed ID: 33387467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition Mechanism of SARS-CoV-2 Infection by a Cholesterol Derivative, Nat-20(S)-yne.
    Murae M; Sakai S; Miyata N; Shimizu Y; Okemoto-Nakamura Y; Kishimoto T; Ogawa M; Tani H; Tanaka K; Noguchi K; Fukasawa M
    Biol Pharm Bull; 2024; 47(5):930-940. PubMed ID: 38692871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives.
    Tandon R; Sharp JS; Zhang F; Pomin VH; Ashpole NM; Mitra D; McCandless MG; Jin W; Liu H; Sharma P; Linhardt RJ
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33173010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of ACE2-Spike Interaction by an ACE2 Binder Suppresses SARS-CoV-2 Entry.
    Shin YH; Jeong K; Lee J; Lee HJ; Yim J; Kim J; Kim S; Park SB
    Angew Chem Int Ed Engl; 2022 Mar; 61(11):e202115695. PubMed ID: 35043545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection.
    Carlos AJ; Ha DP; Yeh DW; Van Krieken R; Tseng CC; Zhang P; Gill P; Machida K; Lee AS
    J Biol Chem; 2021; 296():100759. PubMed ID: 33965375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and structural optimization of 3-O-β-chacotriosyl oleanane-type triterpenoids as potent entry inhibitors of SARS-CoV-2 virus infections.
    Li H; Cheng C; Li S; Wu Y; Liu Z; Liu M; Chen J; Zhong Q; Zhang X; Liu S; Song G
    Eur J Med Chem; 2021 Apr; 215():113242. PubMed ID: 33588180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Clinical-Stage Cysteine Protease Inhibitor blocks SARS-CoV-2 Infection of Human and Monkey Cells.
    Mellott DM; Tseng CT; Drelich A; Fajtová P; Chenna BC; Kostomiris DH; Hsu J; Zhu J; Taylor ZW; Kocurek KI; Tat V; Katzfuss A; Li L; Giardini MA; Skinner D; Hirata K; Yoon MC; Beck S; Carlin AF; Clark AE; Beretta L; Maneval D; Hook V; Frueh F; Hurst BL; Wang H; Raushel FM; O'Donoghue AJ; de Siqueira-Neto JL; Meek TD; McKerrow JH
    ACS Chem Biol; 2021 Apr; 16(4):642-650. PubMed ID: 33787221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Dual-Targeted Fusion Inhibitor Clofazimine Binds to the S2 Segment of the SARS-CoV-2 Spike Protein.
    Freidel MR; Vakhariya PA; Sardarni SK; Armen RS
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the SARS-CoV-2 spike glycoprotein prefusion conformation: virtual screening and molecular dynamics simulations applied to the identification of potential fusion inhibitors.
    Romeo A; Iacovelli F; Falconi M
    Virus Res; 2020 Sep; 286():198068. PubMed ID: 32565126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecules targeting a novel homotrimer cavity of Spike protein attenuate replication of SARS-CoV-2.
    Daniels A; Padariya M; Fletcher S; Ball K; Singh A; Carragher N; Hupp T; Tait-Burkard C; Kalathiya U
    Antiviral Res; 2024 Aug; 228():105949. PubMed ID: 38942150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE2-Independent Interaction of SARS-CoV-2 Spike Protein with Human Epithelial Cells Is Inhibited by Unfractionated Heparin.
    Partridge LJ; Urwin L; Nicklin MJH; James DC; Green LR; Monk PN
    Cells; 2021 Jun; 10(6):. PubMed ID: 34200372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis.
    Bayati A; Kumar R; Francis V; McPherson PS
    J Biol Chem; 2021; 296():100306. PubMed ID: 33476648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potent small molecule inhibitors of SARS-CoV-2 entry.
    Mediouni S; Mou H; Otsuka Y; Jablonski JA; Adcock RS; Batra L; Chung DH; Rood C; de Vera IMS; Rahaim R; Ullah S; Yu X; Getmanenko YA; Kennedy NM; Wang C; Nguyen TT; Hull M; Chen E; Bannister TD; Baillargeon P; Scampavia L; Farzan M; Valente ST; Spicer TP
    SLAS Discov; 2022 Jan; 27(1):8-19. PubMed ID: 35058179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro.
    Morokutti-Kurz M; Fröba M; Graf P; Große M; Grassauer A; Auth J; Schubert U; Prieschl-Grassauer E
    PLoS One; 2021; 16(2):e0237480. PubMed ID: 33596218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Snake venom phospholipase A
    Siniavin AE; Streltsova MA; Nikiforova MA; Kudryavtsev DS; Grinkina SD; Gushchin VA; Mozhaeva VA; Starkov VG; Osipov AV; Lummis SCR; Tsetlin VI; Utkin YN
    Cell Mol Life Sci; 2021 Dec; 78(23):7777-7794. PubMed ID: 34714362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.